Tenon Medical appoints Thomas Henry Batton Jr.

The vesting schedule places one-third on October 1, 2027, with the remaining two-thirds vesting in four equal semi-annual installments, subject to continued service.

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Tenon Medical, Inc. reported that Chief Revenue Officer Thomas Henry Batton Jr. received a grant of 10,000 restricted stock units upon his appointment. Each RSU represents a contingent right to receive one common share upon vesting. The award was made under the Tenon Medical, Inc. 2022 Equity Incentive Plan and vests over three years, subject to continued service; it has no expiration date.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Batton Thomas Henry Jr

Role Chief Revenue Officer

Type	Security	Shares	Price	Value
holding	Restricted Stock Units ^{F1, F2}	--	--	--

Holdings After Transaction: Restricted Stock Units — 10,000 contracts (Direct)

Footnotes (2)

F1. Represents a grant of restricted stock units ("RSUs") under the Tenon Medical, Inc. 2022 Equity Incentive Plan, as amended, upon the Reporting Person's appointment to serve as a Chief Revenue Officer of the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share, upon vesting.
F2. The RSUs vest over three years, with one-third vesting on October 1, 2027 and the remaining two-thirds vesting in four equal semi-annual installments thereafter, subject to the Reporting Person's continued service. The RSUs do not have an expiration date.

Key Figures

Restricted stock units granted: 10,000 units Underlying common shares: 10,000 shares Vesting term: 3 years +2 more

5 metrics

Restricted stock units granted 10,000 units Grant upon appointment as Chief Revenue Officer

Underlying common shares 10,000 shares Each RSU represents a contingent right to receive one common share upon vesting

Vesting term 3 years Subject to continued service

First vesting portion One-third Vests on October 1, 2027

Subsequent vesting installments 4 equal semi-annual installments For the remaining two-thirds of the RSUs

Key Terms

restricted stock units, contingent right, vesting, 2022 Equity Incentive Plan

4 terms

restricted stock units financial

"grant of restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"contingent right to receive one share"

vesting financial

"upon vesting"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

2022 Equity Incentive Plan financial

"under the Tenon Medical, Inc. 2022 Equity Incentive Plan"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many RSUs did Tenon Medical's chief revenue officer receive?

Chief Revenue Officer Thomas Henry Batton Jr. received a grant of 10,000 restricted stock units upon his appointment.

What is the vesting schedule for Tenon Medical's RSU grant?

The RSUs vest over three years, with one-third vesting on October 1, 2027 and the remaining two-thirds in four equal semi-annual installments thereafter, subject to continued service.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 10/09/2026 - 04:02 PM Accepted by SEC EDGAR 10/09/2026 - 04:01 PM

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Batton Thomas Henry Jr

(Last)

(First)

(Middle)

C/O TENON MEDICAL, INC.

104 COOPER CT.

(Street)

LOS GATOS

CALIFORNIA

95032

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
10/01/2026

3. Issuer Name and Ticker or Trading Symbol
Tenon Medical, Inc. [ TNON ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Revenue Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Restricted Stock Units⁽¹⁾	⁽²⁾	⁽²⁾	Common Stock	10,000	⁽¹⁾	D

Explanation of Responses:

1. Represents a grant of restricted stock units ("RSUs") under the Tenon Medical, Inc. 2022 Equity Incentive Plan, as amended, upon the Reporting Person's appointment to serve as a Chief Revenue Officer of the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share, upon vesting.

2. The RSUs vest over three years, with one-third vesting on October 1, 2027 and the remaining two-thirds vesting in four equal semi-annual installments thereafter, subject to the Reporting Person's continued service. The RSUs do not have an expiration date.

	/s/ Thomas Batton Jr.	10/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR